M05.252

Clinical Causes: Chronic inflammation from rheumatoid arthritis damaging blood vessel walls. Autoimmune response where the immune system mistakenly attacks blood vessels. Prolonged disease activity in rheumatoid arthritis increasing the risk. Potential genetic predisposition influencing immune system behavior. Environmental factors such as smoking or infections may contribute, though evidence is limited.

Key Symptoms: Skin changes, including rashes, ulcers, or purplish spots (palpable purpura). Joint pain, swelling, and stiffness, especially near the affected hip. Nerve damage causing numbness, tingling, or weakness. Fever and fatigue due to systemic inflammation. Muscle weakness or pain in the affected area. In severe cases, organ involvement may lead to additional symptoms depending on the affected sites.

Diagnosis Path: Medical history review focusing on rheumatoid arthritis progression and vascular symptoms. Physical examination to assess skin changes, joint status, and nerve function. Blood tests including markers of inflammation (ESR, CRP), rheumatoid factor (RF), and anti-CCP antibodies. Imaging studies such as X-rays or MRI of the left hip to evaluate joint damage and soft tissue involvement. Biopsy of skin or affected tissues to confirm vasculitis by examining blood vessel inflammation. Additional tests (angiography) may be performed to look at blood vessel integrity.

Treatment Protocols: Immunosuppressive medications such as corticosteroids to reduce inflammation. Disease-modifying antirheumatic drugs (DMARDs) like methotrexate to manage RA activity. Biologic agents targeting specific parts of the immune system may be considered. Supportive care including pain management, physical therapy, and wound care if skin ulcers develop. Monitoring for organ involvement and managing complications promptly. Lifestyle modifications like smoking cessation and maintaining an active, healthy lifestyle.